RxDoctor Payments Data

Christopher Lotufo, DPM

Foot & Ankle Surgery · Vancouver, WANPI 1215909452

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $20,961 of the $28,160 with a category attached, or 74.4%. 15 manufacturers reported payments, led by Medical Device Business Services, Inc. at 46.0% of the total. Reporting peaked in 2021 at $9,141 and has fallen 85.2% since, to $1,352 in 2025. Among foot & ankle surgery clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,160in general payments, 2019–2025

Across 83 payments — averaging $339.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$13K
  • Novastep Inc.$9K
  • Stryker$3K
  • Restor3d, Inc.$1K
  • Medline Industries LP$792
  • Johnson & Johnson$340
  • plus $1K from 9 others

What the payments were for

  • Consulting fees$20,96174%
  • Travel & lodging$3,74913%
  • Food & beverage$3,45012%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,160 in reported general payments places this provider in the 95th percentile of 203 foot & ankle surgery providers in Washington.

See all foot & ankle surgery providers in Washington

Medicare billing

Part B allowed, 2024
$147,245
Medicare patients
486
Services billed
3,208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl26$1,783
Ondansetron OdtOndansetron105$772
Diclofenac Sodium104$647
Methylprednisolone52$438
Oxycodone Hcl71$248
Celecoxib20$201
Gabapentin37$194
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen21$97
Cephalexin12$41
Meloxicam16$39
Tramadol Hcl21$39

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Vancouver

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →